New Brunswick “Mystery Illness” Findings Point to Diagnosable Conditions, Not Novel Syndrome
A new provincial study suggests the cluster of unexplained neurological symptoms in New Brunswick, Canada, are likely attributable to existing, diagnosable illnesses, rather than a unique environmental syndrome. The findings, released Friday, are prompting further review by federal health officials and offering a potential path toward support for affected patients.
Mounting Evidence of Existing Conditions
According to a senior official, the latest research reveals “mounting evidence that these patients have diagnosable conditions.” The province is “certainly concerned about that and about patient care,” the official added. The data from the study will be shared with neurologist Dr. Marrero, with an emphasis on ensuring he “understand[s] what we’ve found from our analysis.” The Public Health Agency of Canada will also conduct a further review of the data.
This study marks the second investigation into the cluster of cases, which initially raised concerns about a potential novel neurological syndrome. A previous study, published in 2022, examined the first 48 patients and similarly found no common environmental exposures, concluding that patients were likely experiencing a range of different illnesses.
JAMA Neurology Study Echoes Provincial Findings
Last year, a research paper published in the JAMA Neurology journal reinforced these conclusions. The paper, based on a review of 25 cases, found that all patients had suffered from known and diagnosable illnesses, including cancer and dementia.
Dr. Anthony Lang, the lead author of the JAMA Neurology paper, stated on Friday that the provincial report “confirms our suspicion or belief that there was no environmental factor that could have accounted for such a broad range of neurological problems.” He added, “There was no consistent neurological disease that we had seen in this small group of patients we described,” emphasizing the suffering experienced by patients and their families.
Patients Express Hope and Distrust
Sarah Nesbitt, a patient within the cluster and an environmental advocate, expressed cautious optimism about the study’s potential to help patients, particularly those with elevated levels of metals in their systems. “At the end of the day, it’s about finding the problem with the patients, helping them heal or cure or symptom manage,” she said. However, Nesbitt also voiced concerns about the limitations of the study, noting that some patients did demonstrate elevated levels of metals in their systems.
Despite the findings, Nesbitt and other patients have defended Dr. Marrero, rejecting accusations that he misdiagnosed patients. They maintain he rightfully raised concerns regarding elevated metal levels found in test results. Some patients have expressed a deep distrust of the medical establishment, with Nesbitt noting that several “do not want to see another neurologist ‘because they don’t trust anybody anymore.’” She described Dr. Marrero as “a kind man, he’s intelligent, he does due diligence,” and praised his extensive testing efforts to provide answers.
Dispute Over Initial Syndrome Claims
Dr. Marrero has not yet responded to a request for comment regarding Friday’s report. However, in a September interview with the BBC, he stated that other senior federal and provincial scientists initially believed in the existence of a novel syndrome in New Brunswick. He now feels he is being unfairly portrayed as the sole proponent of this idea. “They are trying to present me as it,” he said. “I was part of it, but I was not it. The only difference is, when the table was empty, I stayed.”
The ongoing investigation highlights the complexities of diagnosing and understanding rare and unexplained medical conditions, and the importance of continued research and patient support.
Related reading
